Evaluation of Children with Stenotrophomonas maltophilia Bacteremia; [Stenotrophomonas maltophilia Bakteriyemili Çocuk Olguların Değerlendirilmesi]
dc.contributor.author | Yeşil E. | |
dc.contributor.author | Çelebi S. | |
dc.contributor.author | Özaslan Z. | |
dc.contributor.author | Özer A. | |
dc.contributor.author | Kilimci D.D. | |
dc.contributor.author | Hacımustafaoğlu M. | |
dc.date.accessioned | 2024-07-22T08:02:48Z | |
dc.date.available | 2024-07-22T08:02:48Z | |
dc.date.issued | 2023 | |
dc.description.abstract | Introduction: Stenotrophomonas maltophilia (S. maltophilia) is a resistant gram-negative rod that can often cause serious infections, especially in patients with long hospital stays and using broad-spectrum antibiotics. In this study, clinical data, and mortality-related risk factors of patients with S. maltophilia bacteremia were evaluated. Materials and Methods: Patients with S. maltophilia bacteremia included in this study and evaluated retrospectively, when hospitalized between 2013 and 2018 in our pediatric wards and intensive care units. Results: A total of 67 patients had 100 S. maltophilia bacteremia in 70 different episodes. Sixty percent (n=40) of the cases were male and their median age were 9 months. Sixty-nine percent (n=46) of the cases were admitted in intensive care units. The most common comorbidity was malignancy. All bacteremias were healthcare associated, and 55% (n=55) were catheter-related. In the total of 70 episodes; 57% (n=37) of the patients had central venous catheters, 47% (n=33) were entubated. Fourty-seven percent (n=33) of the patients had broad spectrum antibiotic use over 14 days. In the blood cultures, 98% of S. maltophilia-producing strains were sensitive to trimethoprim-sulfamethoxazole. Ciprofloxacin and trimethoprim-sulfamethoxazole combination therapy had used for treatment. The mortality rate in the first 30 days was 16% (n=11). Mechanical ventilation was found to be significant (p<0.05) as a predisposing factor related to mortality. Conclusion: Stenotrophomonas maltophilia is the causative pathogen in healthcare associated bloodstream infections especially in intensive care unit. In our study, 69% of the cases were admitted in the intensive care unit and mechanical ventilation status increased mortality. © 2023, Galenos Publishing House. All rights reserved. | |
dc.identifier.DOI-ID | 10.4274/jcp.2023.61482 | |
dc.identifier.issn | 13049054 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/12001 | |
dc.language.iso | English | |
dc.publisher | Galenos Publishing House | |
dc.rights | All Open Access; Bronze Open Access | |
dc.subject | aminoglycoside | |
dc.subject | antibiotic agent | |
dc.subject | carbapenem | |
dc.subject | cephalosporin | |
dc.subject | cotrimoxazole | |
dc.subject | glycopeptide | |
dc.subject | adult | |
dc.subject | antibiotic sensitivity | |
dc.subject | Article | |
dc.subject | bacteremia | |
dc.subject | bacterium isolation | |
dc.subject | bladder catheterization | |
dc.subject | blood culture | |
dc.subject | catheter infection | |
dc.subject | child | |
dc.subject | comorbidity | |
dc.subject | controlled study | |
dc.subject | demographics | |
dc.subject | evaluation study | |
dc.subject | female | |
dc.subject | hospitalization | |
dc.subject | human | |
dc.subject | infant | |
dc.subject | major clinical study | |
dc.subject | male | |
dc.subject | mortality rate | |
dc.subject | neutropenia | |
dc.subject | nonhuman | |
dc.subject | parenteral nutrition | |
dc.subject | pediatric intensive care unit | |
dc.subject | pediatric ward | |
dc.subject | risk factor | |
dc.subject | Stenotrophomonas maltophilia | |
dc.title | Evaluation of Children with Stenotrophomonas maltophilia Bacteremia; [Stenotrophomonas maltophilia Bakteriyemili Çocuk Olguların Değerlendirilmesi] | |
dc.type | Article |